Optimising Perioperative Outcomes: A Practical Guide to Cardiac Biomarkers in Noncardiac Surgery
The 2025 Expert Consensus on cardiac biomarkers strongly recommends using hs-cTn, often combined with BNP/NT-proBNP, for both preoperative risk assessment and postoperative surveillance (daily for 48-72 hours) in high-risk...
Related Links
- Implementing 0/1-Hour Algorithm using High-Sensitivity Cardiac Troponin in the Emergency Department
- The effectiveness of telemonitoring and integrated personalised diabetes management in people with insulin-treated type 2 diabetes mellitus
- Chinese expert consensus on the risk assessment and management of panvascular disease in patients with type 2 diabetes mellitus (2022 edition)
- Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients
- Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers
- Guidelines Interpretation – Guidelines for the management of chronic heart failure in dialysis patients in China
- STRONG-HF Trial highlighting benefits of treatment optimisation
- Rapid Algorithms for Faster Triage of ED Patients with Suspected AMI – What Are We Waiting For?